chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vasovagal Syncope starting five minutes after injection lasting about 20 minutes. BP fluctuated. Heart rate and O2 were normal. Monitored for approximately 30 minutes and then released. Abdominal pain started 3 hours after vaccination. Pain worsened and became severe over several hours, peaking with other flu-like symptoms and decreased over the next several days as other symptoms decreased. Pain was worse on left side about half way up rib cage and lasted for 5 days. Abdominal pain was worse and sharpened when twisting, rolling or bending torso.  I can still feel a pulling sensation under ribs on left side off and on.  Also starting about 15 hours after vaccination I had brownish colored urine that lasted about 36 hours.  Saw FNP 10 days after vaccination. CBC, liver & kidney function blood work & urine dip stick tests all normal.  They could not feel any enlargement on physical examination, but suspect spleen issue
This spontaneous report as received from a patient's mother refers to a currently 56 years old male patient. The patient was immunocompromised due to a stroke (reported as stoke) he had 9 years ago. On an unspecified date, the patient was vaccinated with the dose of LIQUID PEDVAXHIB (reported as unspecified flu shot) injection (dose, lot# and expiration date were not reported) which resulted in high fevers. The outcome of high fevers and the causality between high fevers and LIQUID PEDVAXHIB were not provided. This is one of several reports from the same source. Additional information has been requested.
Shortness of breath chest pain severe headache.  Multiple blood clots stent placed in one and taking medication now to help with the other blockages.
Fever 103.8 aches chills headache mild congestion and cough fatigue about 14 hours after vaccine. Second day same symptoms but fever 101.2
Flu like symptoms, severe aches and pains, chills, headache, slight nausea, extreme tiredness. I began to feel symptoms exactly 19 hrs after the second Pfizer shot. Started with chills in the afternoon, by 4 pm I was down and out, had awful chills and eventually a headache set in. I have never had a reaction like this to a vaccine. Honestly, it is quite alarming.
Pt developed racing heart rate about 5 minutes post injection.  HR jumped as high as 156 recorded, stayed high for a few minutes then went back to normal. Over then next 30 minutes had multiple episodes of her HR jumping up again and then going back to normal.  Pt received a dose of benedryl to treat symptoms. Pt monitored for 1 hour at which time she was felt to be stable. Pt provided with instructions to go to ER if symptoms reoccur.
is taking Ilumya /received the flu shot, which is an inactive vaccine; This case was reported by a consumer via other manufacturer and described the occurrence of drug interaction in a male patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   Co-suspect products included TILDRAKIZUMAB (ILUMYA) for immunosuppression.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season and ILUMYA. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced drug interaction. On an unknown date, the outcome of the drug interaction was unknown.   It was unknown if the reporter considered the drug interaction to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. The Patient was taking Ilumya and the patient had been asking reading the use of immunosuppressive can engage the effect of the Covid 19 vaccine as patient had took the Johnson and Johnson vaccine and enquired about the studies on the efficacy of the vaccine in Ilumya treated patients. The patient had concerned about "inactive vaccines" as he had received the flu shot, which was an inactive vaccine. It was unknown if the reporter considered the drug interaction to be related to ILUMYA. No other information was reported.
After vaccination of my son on 10/27/2016, he had pneumonia and ear infection twice (First in November 2016 and second in January 2017). 2017 is constant cold and breathing problems. His immune system went down so badly after vaccination that we started Albuterol in January 2017 because of asthmatic components with pneumonia and we still on it plus Budesonide with each single cold my son has. Before vaccination he never had cold or other respiratory distresses. It is so vivid that cause of our problems now is the vaccine.
Pt. reported dizziness, joint pain, fatigue, N/V/D after second dose of Shingrix received at pharmacy.
Mom states called on 8/16/01 and stated child broke out with about 23 blisters on chest.
Patient stated that she received a pain in her lower abdomen.  She woke up in the middle of the night with a fever and loose bowel movement. When she made it back to her bed she started vomiting. Patient also states that she had a serve headache. Patient stated that she had loose stool for five days. She could only keep down water and sports drink.
Subdural Hematoma- Brain bleed paralyzed on my entire right side and Craniotomy
Heart racing, patient felt sweaty and dizzy, was diaphoretic.  Brought patient in separate room, he had water, juice, ate a granola bar and calmed down after 45 minutes.  His parents were at the clinic, he went home with them.
Patient fainted shortly (5 minutes or less)  after receiving fluzone quadrivalent.  No redness at injection site, no hives, no difficulty breathing. She was unconscious  for 5 to 10 seconds. EMS was called. EMS personnel thought syncopal episode was due to anxiety.
Nickle size muscle wasting left lower deltoid. Patient noticed 11/13/07. No pain or weakness. Treatment - Physical Therapy. 10/23/07 TDap and 11/6/07 Flu vaccine (Both left deltoid)
11 Adult patients received Bivalent booster from vials that experienced excursion in the refrigerator on 03OCT2022; No adverse event; 11 Adult patients received Bivalent booster from vials that experienced excursion in the refrigerator on 03OCT2022; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (11 Adult patients received Bivalent booster from vials that experienced excursion in the refrigerator on 03OCT2022), PRODUCT TEMPERATURE EXCURSION ISSUE (11 Adult patients received Bivalent booster from vials that experienced excursion in the refrigerator on 03OCT2022) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 immunisation.     No Medical History information was reported.    In October 2022, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In October 2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (11 Adult patients received Bivalent booster from vials that experienced excursion in the refrigerator on 03OCT2022). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (11 Adult patients received Bivalent booster from vials that experienced excursion in the refrigerator on 03OCT2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (11 Adult patients received Bivalent booster from vials that experienced excursion in the refrigerator on 03OCT2022), PRODUCT TEMPERATURE EXCURSION ISSUE (11 Adult patients received Bivalent booster from vials that experienced excursion in the refrigerator on 03OCT2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for POOR QUALITY PRODUCT ADMINISTERED (11 Adult patients received Bivalent booster from vials that experienced excursion in the refrigerator on 03OCT2022) and PRODUCT TEMPERATURE EXCURSION ISSUE (11 Adult patients received Bivalent booster from vials that experienced excursion in the refrigerator on 03OCT2022).    No concomitant medications were reported.  It was reported that the excursion occurred in the refrigerator on 03-Oct-2022 involved 1 unpunctured Red cap vial and 3 unpunctured Bivalent booster vials. Temperature was reported as Min 1.76 Celsius and Max 1.97 Celsius. They no longer had stored the vials, some were used and some were discarded. Excursion duration was reported as 1 Hour & 40 Minutes. It was the first time those vials experienced excursion. Since the excursion date total 11 Adult patients received booster doses from the Bivalent vials on 03-Oct-2022 and 05-Oct-2022 and 3 patients had received Monovalent primary doses from the red cap vial on 19-Oct-2022.  No treatment details were reported.
Pt complains of chest pain difficulty breathing, myalgias.  05/31/2007 MR received from overseas hospital written in German.   DX: Myokarditis.  Massive lokale Impfreaktion nach Pocken-und Milzbrandimpfung am rechten Oberarm.
Patient received a booster dose (0.25 ml) Moderna.  She was told to stay for 15 minutes to make sure she was okay.  She is an employee and said she would be around but had to get back to work.  About 5 or so minutes after receiving the vaccine a member of management came to the pharmacy and said the patient had passed out and someone said they saw her having a seizure. 911 was called and I went to the patient.  The patient was breathing, but not responding to voice. Patient is diabetic.  Paramedics came and took over.
RAHS, REDNESS, WARMNESS,  HIVES AND MUSCLE PAIN WHERE THE SHOT WAS GIVEN.
Chills; Fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), FATIGUE (Fatigue) and HEADACHE (Headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 08-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On 09-Mar-2021, the patient experienced CHILLS (Chills), FATIGUE (Fatigue) and HEADACHE (Headache). At the time of the report, CHILLS (Chills), FATIGUE (Fatigue) and HEADACHE (Headache) outcome was unknown.  Action taken was not applicable.
Woke up with a severely swollen uvula and tonsils making it hard to swallow and speak
The vaccine was stored in the fridge on 14Jan2023 and administered on 18Feb2023; no adverse event; Booster Bivalent dose administered after expiration date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Booster Bivalent dose administered after expiration date), PRODUCT STORAGE ERROR (The vaccine was stored in the fridge on 14Jan2023 and administered on 18Feb2023) and NO ADVERSE EVENT (no adverse event) in a 64-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7168B) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 prophylaxis: Moderna COVID-19 Vaccine on 23-Nov-2021. Past adverse reactions to the above products included No adverse event with Moderna COVID-19 Vaccine.    On 18-Feb-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 18-Feb-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Booster Bivalent dose administered after expiration date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vaccine was stored in the fridge on 14Jan2023 and administered on 18Feb2023) and NO ADVERSE EVENT (no adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Booster Bivalent dose administered after expiration date), PRODUCT STORAGE ERROR (The vaccine was stored in the fridge on 14Jan2023 and administered on 18Feb2023) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Booster Bivalent dose administered after expiration date) and PRODUCT STORAGE ERROR (The vaccine was stored in the fridge on 14Jan2023 and administered on 18Feb2023).    Concomitant medications details were not reported by the reporter. Patient did not report any side effects after receiving this dose. Treatment details was not reported by the reporter.
pt recv vax; fussy at 5 mins then progressed to quiet, severe pallor & severe sweating w/ BP 90/40; R=80; R=16;
Injection location has a boil/blister. Extremely sharp stinging sensation when location got wet.
Erythema at site within 24 hours after injection. Symptoms resolved after 48 hours.
injection site raised; 102 temperature; migraine; rash at injection site; This spontaneous case was reported by a consumer and describes the occurrence of MIGRAINE (migraine), INJECTION SITE RASH (rash at injection site), INJECTION SITE SWELLING (injection site raised) and PYREXIA (102 temperature) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Plaque psoriasis.    No Medical History information was reported.   In 2018, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram. In 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MIGRAINE (migraine), INJECTION SITE RASH (rash at injection site), INJECTION SITE SWELLING (injection site raised) and PYREXIA (102 temperature). At the time of the report, MIGRAINE (migraine), INJECTION SITE RASH (rash at injection site), INJECTION SITE SWELLING (injection site raised) and PYREXIA (102 temperature) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications was not provided.  Treatment medications were not provided.   This case was linked to MOD-2021-107576 (Patient Link).
The patient received the vaccine 6 days early. Patient experienced chills, body aches, and a temperature of 101 for a period of less than 24 hours.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. There was no information about the patients concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patients were vaccinated with a doses of GARDASIL 9 following a temperature excursion (lot # L037554, expiration date: 27-Feb-2017). No apparent adverse effects were reported. The outcome of event was not reported. This is one of two reports from the same reporter. Additional information has been requested.
A non-serious report of administration of expired FluMist was received from an Air Force non-commissioned officer and a health care professional in the USA concerning a 26-year-old female. The patient's medical history and concomitant medications were not reported. On 06-Oct-2008, the patient was given FluMist via nasal administration by an immunization health technician. The vaccine was found to be expired (expiration date 24-Mar-2008). The expired lot of FluMist was given to 17 adult individuals including this  patient. The reporter stated that prior to being informed by the immunization clinic, the expired lot of FluMist was already suspended for use by their office and that suspended lot is collected by a contracted company for disposal. There was no adverse event associated with this medication error; therefore, treatment and reporter/sponsor causality assessments are not applicable, and the event is considered resolved. Based on the results of the investigation, the root cause for the medication errors were caused by1) customers not discarding product from previous season and 2) product expiring during the peak of flu season resulting in some medication errors that occurred shortly after the product expired. Follow-up information was received on 09-Apr-2009: Product complaint Investigation results
Pfizer-BioNTech COVID-19 Vaccine EUA Injection site pain Intermittent Chills Intermittent headache Intermittent dizziness Fatigue Soreness in arm of injection
tested positive covid-19; tested positive covid-19; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a representative.  A 8 year-old patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 27Dec2021, outcome unknown. Patient tested positive covid-19 Thursday last week. The patient underwent the following laboratory tests and procedures polymerase chain reaction (23Dec2021) positive, yesterday confirmed with a positive PCR.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
night chills, fever, headache, body aches, loss of taste, swollen discolored (whiteish) tongue with bumps along the perimeter
Reported to vaccine clinic approximately 4 hours after receiving dose one of Pfizer Covid-19 vaccine with complaints of itching, burning feeling on skin and swelling in left arm. Red rash on chest and left arm. No sob, chest pain or difficulty swallowing. Ambulated to emergency room for evaluation.
No negative outcome from vaccine, but was diagnosed with Covid in September and Received monoclonal antibody treatment at an outpatient facility
A couple hours after recieving vaccinations, my daughter started screaming crying. She had always been such a happy baby who rarely cried, so this was out of character for her. The screaming and crying lasted 5 whole days. We took numerous trips (3) to the doctor, and nothing was done. I should have taken her to the emergency room looking back, because I swear she was acting like she had a headache (possible brain swelling from reaction).
I've had both shots.  Issue started after 2nd shot received on 4/20/21 at 11:00 am.  I felt great all that day until I woke up at 1:00 am next day with pain and fatigue of about a 7 on 10 point scale.  That lasted all day and I stayed in bed.  There was less pain and fatigue the following day but instead my heart was racing.  In days since the pain has stopped and fatigue is gone, but I have periods of my heart racing.  Today is 6 days after the second shot almost to the hour.  I feel good at the moment, but did have a short lived episode of heart racing in middle of the night.  Hopefully this is all getting better, but I thought best to report it because everything I've read on Internet suggests that the after affects would only be a day or two.
Redness & swelling lasting 48 hours. Soreness at injection site for 36 hours.
Numbness and tingling in fingers of left hand AND tingling in 3 middle fingertips of RIGHT hand.
Pregnant during first shot; This spontaneous retrospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant during first shot) in a 38-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     The patient's past medical history included Pregnancy (Live, Full-term Birth) since April 2018. Concurrent medical conditions included Drug allergy (Cephzil). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. The patient's last menstrual period was on 26-Jun-2020 and the estimated date of delivery was 15-Mar-2021. On 25-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant during first shot). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-fourth week of the pregnancy. The delivery occurred in March 2021, which was reported as Normal Pregnancy Outcome. For neonate 1, The outcome was reported as Delivered NOS. On 25-Feb-2021, EXPOSURE DURING PREGNANCY (Pregnant during first shot) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2020, Pregnancy test: positive (Positive) Positive. On an unknown date, Blood glucose: normal (normal) Normal. On an unknown date, Ultrasound scan: normal (normal) Normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Treatment information was not provided.   This case was linked to MOD-2021-065323 (Patient Link).
Systemic: Hyperventilation-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild, Systemic: Weakness-Mild, Additional Details: Patient asked about possible side effects from vaccine. They were discussed with her. She asked about why she needed to stay15 minutes after vaccination which was stated to assess for possible allergic reaction. Pt reported she had severe panic attacks in the past and that she was then concerned about allergic reaction. She stated she had numbness at her hand which went away after 30 minutes. she was assessed for 30 minutes. Her anxiety deminished and she wanted to leave.
Pt was doing just fine about 15 minutes into 30 minute observation period pt expressed experiencing the following: numbness on bilateral cheeks and jaw, tingling on tongue, feeling of something in her throat. At the time pt was breathing fine and was listening to calming music and focus on her breathing.  At the 30 min mark pt was still having numbness in the face and mouth as well as dry heaving, dizziness, kneeling on floor, sharp/significant left abdominal pain. Pt was not SOB and had no facial/tongue swelling. Provider determined epi-pen not needed at this time. Pt was then wheeled down to ER where she started to have what she reported as watery diarrhea x 10 minutes w/ abdominal pain.
Swelling, localized pain,  itchiness, redness, localized edema.
After receiving the flu shot on 10/22/17 the next day 10/23/17 I was unable to lift my arm. I had a sharp shooting pain running from my shoulder to my elbow. My arm has continually hurt and I cannot lift my arm above my head. I also cannot rotate my arm. I have a throbbing pain on a constant basis.
I had the Pfizer vaccine dose 1. I have had a regular period the entire time I've had a menstrual cycle. I never experience late or early periods. I have never been pregnant either. However, the day after I got the vaccine (this morning) I woke up with a heavy period. No signs of cramping or other PMS symptoms.  It is 2 weeks early.   I have found multiple women (20+) who have experienced a disruption of their cycle and it is unbelievable I cannot find any actual research on this or reasons why this is occurring yet the vaccine is being pushed onto our nation. Some women I spoke to missed their period, some have been bleeding for weeks. We want answers as to why this is happening and how it is going to affect us in the long-run.